Issue 1,686: April 5, 2023 |
||
Top Stories |
Immunize.org Pages and Handouts
Vaccine Information Statements
Featured Resources
Notable Publications
Top Stories
Adolescent Immunization Action Week (#AIAW23) is here! Held April 3–7 in 2023, #AIAW23 is an annual observance urging parents, healthcare providers, and adolescents to help keep adolescents up to date on immunizations. During the pandemic, many adolescents missed out on critical vaccinations. Concerted efforts are needed now to close this gap. The Unity Consortium created tools to help healthcare providers spread messages to parents, adolescents, and young adults. Materials include ready-to-use graphics, a video, communication tools, and social media materials. Use the hashtag #AIAW23 to spread the word. Celebrate National Public Health Week, April 3–9, with the American Public Health Association’s resources and social media toolkit The American Public Health Association (APHA) coordinates National Public Health Week (NPHW) on April 3–9. This year, the observance celebrates the unique and joyful ways various cultures focus on health. We can learn from each other, with humility and openness.
IZ Express keeps 54,000+ readers up to date on what’s new in vaccines each week; invite your colleagues to subscribe!
Encourage your co-workers to subscribe to IZ Express so they get all the news that matters to vaccinators in their own inbox each Wednesday. IZ Express, the weekly e-newsletter produced by Immunize.org, alerts 54,000+ readers to the week’s important vaccine developments. IZ Express also features:
On the Immunize.org home page, you can link to several of our helpful companion websites. These recent articles convey the potential risks of vaccine-preventable diseases and the importance of vaccination.
Immunize.org Pages and Handouts
Immunize.orgupdates four standing orders templates—for administering measles, mumps, and rubella vaccine to children and teens and to adults, and varicella vaccine to children and teens and to adults
Immunize.org updated four standing orders templates, adding QR codes linking to the online versions of the documents. Changes to the contraindications section include adding the definition of long-term immunosuppressive therapy and including a link to CDC’s hematologic criteria for safe vaccination of HIV-infected individuals. The intramuscular route of administration has been added as an option for M-M-R II and Varivax (Merck); the subcutaneous route remains the only approved route for the MMR vaccine, Priorix (GSK).
Related Links
Back to top
IZ Express regularly provides readers with information about Immunize.org’s new and updated educational materials for healthcare professionals and handouts for patients. All Immunize.org materials are free to distribute.
Vaccine Information Statements With support from CDC, Immunize.org is working with partners to increase the number of Vaccine Information Statement (VIS) translations available.
Featured Resources
Montgomery County Immunization Coalition offers social media toolkit for National Minority Health Month this April
National Minority Health Month (NMHM) is observed in April to highlight the importance of improving the health of racial and ethnic minorities and reducing health disparities. The theme for NMHM 2023 is "Better Health through Better Understanding," focusing on providing culturally and linguistically competent information and resources. Back to top
Immunize.org's laminated versions of the 2023 U.S. child and adolescent immunization schedule and the 2023 U.S. adult immunization schedule are in stock and shipping now. Order while supplies last. Once sold out, we will not print more until 2024. While the schedules are available online from CDC at no cost, Immunize.org’s laminated schedules are ideal for use in any busy healthcare setting. Their tough coating can be wiped down, and they’re durable enough to stand up to a year of use.
Explore the www.Give2MenACWY.org website to increase coverage for the MenACWY booster and other adolescent vaccinations Immunize.org's www.Give2MenACWY.org website promotes the importance of adolescent vaccination, including the recommended MenACWY vaccine booster dose at age 16. Many teens are behind on vaccines because of the pandemic, so vaccine outreach is more important than ever. The website is divided into five easy-to-access sections:
The site also categorizes materials according to whether they are primarily of interest to providers, to adolescents, or to parents.
Notable Publications
Vaccinate Your Family releases its 2023 "State of the ImmUnion" report on vaccine-preventable diseases in the United States
Vaccinate Your Family (VYF) released its annual State of the ImmUnion report, distributed to policy makers in Washington, DC. The report examines the strength of our country’s defenses against vaccine-preventable diseases. Notably, it points out what we can do to make our country more resilient against emerging health threats. Please take a moment to ask your representatives for strong support of vaccines. Share the most recent State of the ImmUnion report by using VYF’s form to send quick and easy emails to members of Congress from your district. You also can share one of VYF's state fact sheets that will help your lawmakers understand the importance of strong vaccination policies in your specific state. “JYNNEOS Vaccination Coverage among Persons at Risk for Mpox—United States, May 22, 2022–January 31, 2023” published in MMWR
CDC published JYNNEOS Vaccination Coverage among Persons at Risk for Mpox—United States, May 22, 2022–January 31, 2023 on March 31 in MMWR. A portion of the summary appears below. JYNNEOS vaccine is effective in preventing monkeypox (mpox) among persons at risk. . . . During the current multinational outbreak, U.S. 1- and 2-dose vaccination coverage reached an estimated 37% and 23%, respectively, among persons at risk, with wide variation among jurisdictions. The predominant administration route switched from subcutaneous to intradermal after the week of August 20, 2022, in accordance with Food and Drug Administration recommendations. . . . Despite administration of >1 million vaccine doses, only 23% of the at-risk population has been fully vaccinated. Targeted outreach and continued access to and availability of mpox vaccines to persons at risk is important to help prevent and minimize the impact of a resurgence of mpox.
For more upcoming events, visit our Calendar of Events.
|